Uremia Clinical Trial
Official title:
Prospective, Multicenter, Randomized, Open Label Study on the Efficacy and Safety of Comparison of KHA80 Blood Perfusion Combined With Hemodialysis and Conventional Hemodialysis in Clearing IL-6, β2-MG and PTH in Maintenance Hemodialysis Patients
To evaluate the decreasing rate of blood IL-6, β2-MG and PTH in maintenance hemodialysis patients in the 52nd week compared with routine hemodialysis.
394 patients with maintenance hemodialysis were included in the study, and the blood purification time was ≥8 hours per week (including routine hemodialysis, high-throughput hemodialysis, hemodialysis filtration, hemoperfusion, etc.). Randomly assign the control group (197 cases) to receive hemodialysis or hemodialysis filtration treatment, and the frequency of treatment is ≥2 times/week; The experimental group (197 cases) were randomly assigned to receive Jianfan KHA80 hemoperfusion treatment on the basis of hemodialysis or hemodiafiltration treatment, and the frequency of hemoperfusion treatment was ≥2 times/month. The follow-up data of 0, 4, 12, 24, 36 and 52 weeks of treatment in the two groups were collected, and the information of combined medication and adverse events was also collected. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT00577967 -
Gabapentin - A Solution to Uremic Pruritus?
|
N/A | |
Completed |
NCT01583309 -
Effects of Convective Therapies in Dialysis Patients
|
Phase 3 | |
Completed |
NCT03437538 -
Reduction Ratio and Clearance During Hemodialysis With MCO-filter Compared to HDF With Standard High-flux Filter
|
N/A | |
Completed |
NCT00649298 -
A Clinical Trial of IntensiVE Dialysis
|
Phase 4 | |
Completed |
NCT05750875 -
Gabapentin Versus Loratadine in Uremic Pruritus
|
Phase 4 | |
Recruiting |
NCT01408797 -
Clonal Deletion on Living-Relative Donor Kidney Transplantation
|
Phase 1/Phase 2 | |
Completed |
NCT01267760 -
Clinical and Biochemical Effects of Multipass Hemodialysis
|
Phase 2 | |
Recruiting |
NCT00375635 -
Removal of Protein Bound Uremic Toxins by Modified Plasma Separation and Adsorption Combined With Hemodialysis
|
N/A | |
Recruiting |
NCT05076318 -
Dysregulated Urea-synthesis at Terminal Uremia
|
N/A | |
Completed |
NCT05899283 -
A Comparative Study of Two Kinds of Hemodialysis Filters
|
N/A | |
Completed |
NCT04768309 -
Impact of Intestinal Microbiota on Uremic Toxins Productions
|
N/A | |
Not yet recruiting |
NCT05386433 -
Paxlovid in the Treatment of COVID-19 Patients With Uremia
|
Early Phase 1 | |
Completed |
NCT01391884 -
Elimination of Incretin Hormones in Patients With Severe Kidney Failure
|
N/A | |
Completed |
NCT00442819 -
Uremic Pruritus, Cytokines and Polymethylmethacrylate Artificial Kidney
|
Phase 4 | |
Not yet recruiting |
NCT02266238 -
Stenosis of Arteria-Venous Fistula in Maintenance Hemodialysis Patients: Early Intervention Trial
|
N/A | |
Recruiting |
NCT01766895 -
Long-term Follow Up of Viral Hepatitis in Uremic Patients in Taiwan
|
||
Completed |
NCT00388648 -
Very Low Protein Diet or Dialysis in Uremic Elderly?
|
Phase 4 | |
Withdrawn |
NCT03416192 -
12 Weeks of Hemodialysis With Medium Cut-Off Filter Compared to Hemodiafiltration With Standard High-flux Filter.
|
N/A | |
Recruiting |
NCT02606955 -
Probing the Dry Weight by Bioimpedance: The Resistance Stabilization Test
|
N/A | |
Recruiting |
NCT02446535 -
Probing the Dry Weight (DW) by Bioimpedance (BIA): Which is the Gold Standard Between Clinical DW and BIA DW?
|
N/A |